New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2013
05:41 EDTGEVASynageva downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray downgraded Synageva on expectations the stock will be range bound as the Phase III CESD trial progresses. The firm lowered its price target for shares to $57 from $66.
News For GEVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for GEVA

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use